Get the app!
Back to Trades

LAI GOLDMAN MYLA

DirectorCIK: 0001168581

LAI GOLDMAN MYLA, Director, has filed 5 insider trading reports covering 3 companies. Total disclosed trading volume is $1.8M. Purchases and sales are approximately balanced over this period. The largest single filing involves Akoya Biosciences, Inc. (AKYA). All transactions sourced from SEC Form 4 filings.

Total Volume
$1.8M
Purchases
$0
Sales
$0
Companies
3

Companies Traded

WEST PHARMACEUTICAL SERVICES INC (WST)Quanterix Corp (QTRX)Akoya Biosciences, Inc. (AKYA)

Trading History (5 filings)

WEST PHARMACEUTICAL SERVICES INC(WST)
LAI GOLDMAN MYLADirector
Filed May 6, 2026
Grant
$0
1 grant
View DetailsSEC Filing
Quanterix Corp(QTRX)
LAI GOLDMAN MYLAInsider
Filed Jan 6, 2026
Grant
$0
2 grants
View DetailsSEC Filing
Quanterix Corp(QTRX)
LAI GOLDMAN MYLAInsider
Filed Oct 3, 2025
Grant
$11.5K
1 grant
View DetailsSEC Filing
Quanterix Corp(QTRX)
LAI GOLDMAN MYLAInsider
Filed Jul 10, 2025
Grant
$0
2 grants
View DetailsSEC Filing
Akoya Biosciences, Inc.(AKYA)
LAI GOLDMAN MYLADirector
Filed Jul 10, 2025
Other
$0
View DetailsSEC Filing